Suchergebnisse
10
Alles
Such-Filter
Organisationen
Novonesis (Novozymes A/S)
Trading by management and close relations of management
27. Februar 2025 03:39 ET
|
Novonesis (Novozymes A/S)
The Executive Leadership Team members eligible for the Novozymes A/S 2022-2024 incentive program has on February 26, 2025, received the allocated shares. An overview of the number and value of shares...
12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025
26. Februar 2025 02:04 ET
|
Novonesis (Novozymes A/S)
Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of...
12M 2024 Company announcement
26. Februar 2025 01:58 ET
|
Novonesis (Novozymes A/S)
2024 organic pro forma sales growth of 8%, with pro forma adjusted EBITDA margin of 36.1%. 2025 outlook of 5-8% organic pro forma sales growth and 37-38% adjusted EBITDA margin. 2024 organic pro...
Change to the Executive Leadership Team
21. Februar 2025 06:24 ET
|
Novonesis (Novozymes A/S)
Jacob Vishof Paulsen will be leaving his position as Executive Vice President of Food & Beverage Biosolutions, as he has accepted a role outside of Novonesis, effective March 31, 2025. Ester...
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
11. Februar 2025 01:13 ET
|
Novonesis (Novozymes A/S)
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5...
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
11. Februar 2025 00:57 ET
|
Novonesis (Novozymes A/S)
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5...
Trading by management and close relations of management
03. Januar 2025 05:23 ET
|
Novonesis (Novozymes A/S)
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Change to Novonesis’ Board of Directors
17. Dezember 2024 04:00 ET
|
Novonesis (Novozymes A/S)
Sharon James will not be seeking re-election to the Board of Directors of Novonesis at the upcoming annual general meeting in 2025 and will step down effectively on December 31, 2024. This decision...
Major shareholder announcement
29. November 2024 09:22 ET
|
Novonesis (Novozymes A/S)
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Major shareholder announcement
27. November 2024 05:09 ET
|
Novonesis (Novozymes A/S)
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...